CNTX logo

Context Therapeutics (CNTX) Free Cash Flow

Annual FCF

-$21.05 M
-$6.96 M-49.42%

December 31, 2023


Summary


Performance

CNTX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTXcash flowmetrics:

Quarterly FCF

-$16.69 M
-$13.33 M-397.37%

September 30, 2024


Summary


Performance

CNTX Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTXcash flowmetrics:

TTM FCF

-$31.63 M
-$13.23 M-71.88%

September 30, 2024


Summary


Performance

CNTX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTXcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

CNTX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-49.4%-397.4%-71.9%
3 y3 years-1934.4%-260.4%-77.9%
5 y5 years-642.1%-260.4%-77.9%

CNTX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-132.6%at low-494.6%at low-249.6%at low
5 y5-year-1934.4%at low<-9999.0%at low<-9999.0%at low
alltimeall time-1934.4%at low<-9999.0%at low<-9999.0%at low

Context Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$16.69 M(+397.4%)
-$31.63 M(+71.9%)
Jun 2024
-
-$3.36 M(-23.0%)
-$18.40 M(-6.5%)
Mar 2024
-
-$4.36 M(-39.7%)
-$19.68 M(-6.5%)
Dec 2023
-$21.05 M(+49.4%)
-$7.23 M(+108.8%)
-$21.05 M(+18.6%)
Sep 2023
-
-$3.46 M(-25.3%)
-$17.75 M(-0.2%)
Jun 2023
-
-$4.63 M(-19.2%)
-$17.78 M(+11.4%)
Mar 2023
-
-$5.73 M(+45.8%)
-$15.96 M(+13.3%)
Dec 2022
-$14.09 M
-$3.93 M(+12.5%)
-$14.09 M(-6.8%)
Sep 2022
-
-$3.49 M(+24.5%)
-$15.12 M(+29.6%)
Jun 2022
-
-$2.81 M(-27.2%)
-$11.67 M(+4.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$3.86 M(-22.3%)
-$11.19 M(+23.6%)
Dec 2021
-$9.05 M(+774.7%)
-$4.96 M(>+9900.0%)
-$9.05 M(+112.2%)
Sep 2021
-
-$43.60 K(-98.1%)
-$4.26 M(-6.7%)
Jun 2021
-
-$2.33 M(+35.8%)
-$4.57 M(+78.4%)
Mar 2021
-
-$1.72 M(+874.6%)
-$2.56 M(+147.7%)
Dec 2020
-$1.03 M(-63.5%)
-$176.00 K(-49.7%)
-$1.03 M(+20.5%)
Sep 2020
-
-$350.20 K(+9.1%)
-$858.60 K(+68.9%)
Jun 2020
-
-$321.00 K(+71.3%)
-$508.40 K(+171.3%)
Mar 2020
-
-$187.40 K
-$187.40 K
Dec 2019
-$2.84 M
-
-

FAQ

  • What is Context Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Context Therapeutics?
  • What is Context Therapeutics annual FCF year-on-year change?
  • What is Context Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Context Therapeutics?
  • What is Context Therapeutics quarterly FCF year-on-year change?
  • What is Context Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Context Therapeutics?
  • What is Context Therapeutics TTM FCF year-on-year change?

What is Context Therapeutics annual free cash flow?

The current annual FCF of CNTX is -$21.05 M

What is the all time high annual FCF for Context Therapeutics?

Context Therapeutics all-time high annual free cash flow is -$1.03 M

What is Context Therapeutics annual FCF year-on-year change?

Over the past year, CNTX annual free cash flow has changed by -$6.96 M (-49.42%)

What is Context Therapeutics quarterly free cash flow?

The current quarterly FCF of CNTX is -$16.69 M

What is the all time high quarterly FCF for Context Therapeutics?

Context Therapeutics all-time high quarterly free cash flow is -$43.60 K

What is Context Therapeutics quarterly FCF year-on-year change?

Over the past year, CNTX quarterly free cash flow has changed by -$13.33 M (-397.37%)

What is Context Therapeutics TTM free cash flow?

The current TTM FCF of CNTX is -$31.63 M

What is the all time high TTM FCF for Context Therapeutics?

Context Therapeutics all-time high TTM free cash flow is -$187.40 K

What is Context Therapeutics TTM FCF year-on-year change?

Over the past year, CNTX TTM free cash flow has changed by -$13.23 M (-71.88%)